Stroke
Conference Coverage
Chronic marijuana use linked to recurrent stroke
“It’s essential to raise awareness among young adults about the impact of chronic habitual use of marijuana, especially if they have established...
From the Journals
Ischemic stroke rates higher in young women than young men
Young women may be at a higher risk of ischemic stroke than young men, representing a “significant departure from our current scientific...
From the Journals
Early, subtle, cardiac changes tied to midlife cognitive decline
Researchers said that “heart health is key to brain health.”
From the Journals
Is outpatient care as safe as inpatient for TIA, minor stroke?
The safety of outpatient care can be improved by correct risk stratification, then triaging patients based on their risk profile.
From the Journals
Who benefits most from device PFO closure after a stroke?
Younger patients with high-risk physiological features but no vascular risk factors may benefit most from patent foramen ovale closure with a...
From the Journals
Blood pressure control worsened during COVID pandemic
Increases in BP in U.S. adults during the COVID-19 pandemic could signal a looming increase in future cardiovascular disease mortality,...
From the Journals
No serious CV risks for elderly after Pfizer COVID-19 vaccine
A French study adds to other evidence that the Pfizer mRNA COVID-19 vaccine does not increase the risk for serious cardiovascular adverse events...
From the Journals
Coffee or tea? Drinking both tied to lower stroke, dementia risk
Drinking coffee or tea reduces the risk for stroke and dementia. But drinking both reduces stroke risk by 30% and dementia risk by 28%.
Conference Coverage
Ticagrelor reversal agent achieves quick hemostasis: REVERSE-IT
The monoclonal antibody bentracimab, which can rapidly reverse ticagrelor, was found effective and safe in an FDA-requested interim analysis of a...
Conference Coverage
ASCEND: Aspirin shows hint of dementia protection in T2D
Conference Coverage
PRAGUE-17: LAA closure holds up against DOACs out to 4 years
Most outcomes remained unchanged, but follow-up imaging curtailed by the COVID-19 pandemic leaves an unfortunate gap with regard to late device-...